An Unlikely Pair: New Pancreatic Cancer Vaccine Utilizes Immunity from Tetanus - BioSpace

Researchers at Albert Einstein College of Medicine have cleverly developed a vaccine for pancreatic cancer by using the adaptive immunity already present in nearly all of the global population.

Anarticle published this week in Science Translational Medicine has provided a possible solution for the daunting task of treating patients with pancreatic cancer. Researchers at Albert Einstein Coll… [+3334 chars]

full article...